Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 5 months ago

CV Disease in Special Populations

Heart Failure
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Revascularisation in Patients with Cancer
Author(s): Miguel Nobre Menezes , Mamas A Mamas Added: 3 weeks ago

CV Disease in Special Populations

Intervention
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 10 months ago

CV Disease in Special Populations

Heart Failure
Alicia Okines
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Consultant Medical Oncologist, Royal Marsden Hospital, London, UK
Dr Alicia Okines is a consultant in medical oncology at the Royal Marsden NHS Foundation Trust and the team leader for the Breast Cancer Systemic Therapy Trials team.Dr Okines studied pharmacology at the University of Sheffield, where she also pursued her medical training. Throughout her oncology residency at The Royal Marsden Hospital and the Institute of Cancer Research, she earned an MD(Res),… View more
Danielle (Dani) Cuthbert
Job title: Medical Oncologist
Dr Danielle (Dani) Cuthbert is a Medical Oncologist at St. Michael’s Hospital and Assistant Professor at the University of Toronto. She completed medical school and internal medicine residency at Northwestern University Feinberg School of Medicine in Chicago. She then returned home to Toronto in 2020 for medical oncology residency followed by a clinical fellowship in breast oncology at Princess… View more
Teresa Taft Levitch is a strategic healthcare communicator, writer, and patient advocate whose work focuses on cancer rehabilitation, survivorship, and cardiovascular health. She has developed patient-centered content and campaigns for organisations including the CDC Foundation, AstraZeneca, Memorial Sloan Kettering Cancer Center, the American Heart Association, and the Cancer Survivorship &… View more
Susan Dent
Research Area(s) / Expertise:

Cardio-oncology

 Job title: President IC-OS and Co-Director Cardio-Oncology
Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff… View more
Lawrence N. Shulman
Job title: Deputy Director
Dr Lawrence N Shulman is Deputy Director for Clinical Services at the Abramson Cancer Center at the University of Pennsylvania. He is also Director of the Center for Global Cancer Medicine. Currently Dr Shulman is Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. Formerly, he was Chair of the American Society of Clinical Oncology Quality… View more
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 10 months ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery